Transaction in Own Shares

Summary by AI BETAClose X

On October 10, 2025, GSK plc, acting through BNP Paribas SA, purchased 355,000 of its own ordinary shares with a nominal value of 31¼ pence each. The lowest price paid per share was 1,623.00p, while the highest price reached 1,646.00p, resulting in a volume-weighted average price of 1,635.50p. These shares will be held as treasury shares, as part of the company's existing buyback program announced on September 30, 2025. Since then, GSK has purchased 2,904,000 ordinary shares. Following this transaction, GSK will hold 250,368,844 ordinary shares in treasury, with 4,065,044,985 ordinary shares in issue, excluding treasury shares; the percentage of voting rights attributable to the ordinary shares held in treasury is 6.16 per cent.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings